Ashleigh Tuite
Assistant Professor
University of Toronto Dalla Lana School of Public Health




Senior Epidemiologist
BlueDot Inc.


Postdoctoral Research Fellow (previously held)
Boston Medical Center
Medicine
Infectious Diseases

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Gebretekle GB, Yeung MW, Ximenes R, Cernat A, Simmons AE, Killikelly A, Siu W, Rafferty E, Brousseau N, Tunis M, Tuite AR. Cost-effectiveness of RSVpreF vaccine and nirsevimab for the prevention of respiratory syncytial virus disease in Canadian infants. Vaccine. 2024 Jul 29; 126164. PMID: 39079810
     
  2. Fisman DN, Simmons AE, Tuite AR. Case-cohort design as an efficient approach to evaluating COVID-19 vaccine effectiveness, waning, heterologous immune effect and optimal dosing interval. Vaccine. 2024 Jul 13. PMID: 39004528
     
  3. Brankston G, Fisman DN, Poljak Z, Tuite AR, Greer AL. Examining the effects of voluntary avoidance behaviour and policy-mediated behaviour change on the dynamics of SARS-CoV-2: A mathematical model. Infect Dis Model. 2024 Sep; 9(3):701-712. PMID: 38646062; DOI: 10.1016/j.idm.2024.04.001;
     
  4. Fisman DN, Amoako A, Simmons A, Tuite AR. Impact of immune evasion, waning and boosting on dynamics of population mixing between a vaccinated majority and unvaccinated minority. PLoS One. 2024; 19(4):e0297093. PMID: 38574059; DOI: 10.1371/journal.pone.0297093;
     
  5. Peng A, Bosco S, Simmons AE, Tuite AR, Fisman DN. Impact of community mask mandates on SARS-CoV-2 transmission in Ontario after adjustment for differential testing by age and sex. PNAS Nexus. 2024 Feb; 3(2):pgae065. PMID: 38463611; DOI: 10.1093/pnasnexus/pgae065;
     
  6. Yan P, Mullah MAS, Tuite A. A proportional incidence rate model for aggregated data to study the vaccine effectiveness against COVID-19 hospital and ICU admissions. Biometrics. 2023 Dec; 79(4):3954-3967. PMID: 37561066
     
  7. Lin YJ, Evans DH, Robbins NF, Orjuela G, Abe KT, Rathod B, Colwill K, Gingras AC, Tuite A, Yi QL, O'Brien SF, Drews SJ. Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021. Microbiol Spectr. 2023 Aug 17; 11(4):e0525622. PMID: 37289096; DOI: 10.1128/spectrum.05256-22;
     
  8. Tuite AR, Ng V, Ximenes R, Diener A, Rafferty E, Ogden NH, Tunis M. Quantifying the economic gains associated with COVID-19 vaccination in the Canadian population: A cost-benefit analysis. Can Commun Dis Rep. 2023 Jun 01; 49(6):263-273. PMID: 38440772; DOI: 10.14745/ccdr.v49i06a03;
     
  9. Peng A, Simmons A, Amoako A, Tuite A, Fisman D. Relative pandemic severity in Canada and four peer nations during the SARS-CoV-2 pandemic. Can Commun Dis Rep. 2023 May 01; 49(5):197-205. PMID: 38419909; DOI: 10.14745/ccdr.v49i05a05;
     
  10. Simmons AE, Amoako A, Grima AA, Murison KR, Buchan SA, Fisman DN, Tuite AR. Vaccine effectiveness against hospitalization among adolescent and pediatric SARS-CoV-2 cases between May 2021 and January 2022 in Ontario, Canada: A retrospective cohort study. PLoS One. 2023; 18(3):e0283715. PMID: 37000810; DOI: 10.1371/journal.pone.0283715;
     
Showing 10 of 121 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 121 publications over 20 distinct years, with a maximum of 24 publications in 2020

YearPublications
20031
20042
20052
20061
20093
20106
20117
20122
20139
20145
20151
20162
20175
20184
201910
202024
202111
202212
20239
20245

Note: Tweets will show if you have logged into X.com. Otherwise you will see a message that there is nothing to see yet.
Contact for Mentoring:

Tuite's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_